Breaking NewsUK CBD Novel Food Application Deadline Delayed By Seven...

UK CBD Novel Food Application Deadline Delayed By Seven Weeks

-

THE UK’s deadline for Novel Food submissions has now been officially moved with the Food Standards Agency (FSA) struggling to handle the welter of applications.

The FSA had perviously said that April 1, would be the date it would publish a list of all the products that could remain on the UK market.

To do this it expected all applications to be submitted by Monday February 8 allowing eight working days for an Administrative check and a further 30  working days for Validation.

However, an announcement today from the FSA said the deadline for applications had now been pushed back until March 31.

Further Analysis On Likely Winners Tomorrow

Emily Miles, Chief Executive of the Food Standards Agency, said: “Applying for novel food authorisation is the only way CBD products can remain on sale here. For the past year, we’ve been encouraging all businesses to submit good quality applications as a matter of urgency. 

“However, we have received a large number of applications close to the deadline. This means that, in order to process these properly, we are adapting the criteria of products allowed to remain on sale from April 1.

“For some time now we’ve been supporting a pragmatic and proportionate approach to CBD regulation. Our commitment to ensuring that consumers know these products are being checked for safety remains firm.”

It went on to say list of products linked to validated applications will be published on the FSA’s website in April and regularly updated. 

*BusinessCann is following this story closely and recently reported that over 400 applications had been received by the end of February. Tomorrow we will be publishing an analysis of this process and who the likely winners will be.

Peter
Peter
Peter McCusker is an experienced news and business editor, who believes it’s time to fully embrace the multiple, proven, medical benefits of the cannabis plant.

Latest news

Treasury Should “Unlock” Cannabis Economic Benefits, Says CIC

PRESS RELEASE THE Treasury has been urged to ”unlock the very significant economic potential” of the medical cannabis, hemp, and...

Bloomwell Group Closes Multi-Million Euro Growth Capital Round With Leading US Venture Capital Investors, And Award-Winning Actor, Moritz Bleibtreu

PRESS RELEASE FRANKFURT-based medical cannabis holding company Bloomwell Group (“Bloomwell,” “Bloomwell Group,” or the “Company”) has closed a significant multi-million Euro funding...

Norway Hosts First Public Meeting On Medical Cannabis Amid ‘Early First Steps’ Towards Potential Reform

NORWAY, one of the most cautious states in Europe when it comes to cannabis liberalisation, recently held a public...

Cutbill Jacoby PR Launches To Focus On Emerging Industries

PRESS RELEASE Cutbill Jacoby, a London-based Communications and PR agency for emerging industries, launches to initially service the fast-growing industrial...

Sana Healthcare Becomes Script Assist: Company Rebrands To Focus On Innovative Problem-Solving Platform

SANA Healthcare will from today be known as Script Assist after the company’s innovative platform which provides clinicians with...

Love Hemp ‘Rigorously Refutes’ Allegations Of Fraud Levelled By Former Managing Director

LOVE Hemp has responded to damning allegations made publicly by its former managing director Philip Small, who left the...

Must read

Love Hemp ‘Rigorously Refutes’ Allegations Of Fraud Levelled By Former Managing Director

LOVE Hemp has responded to damning allegations made publicly...

You might also likeRELATED
Recommended to you